Get subscribed to our newsletter
Get interesting updates to your email inbox.
Each change is a step towards transformation. Ever since the pandemic interrupted our lives, the shift to remote working has not just altered the place where we work from but also its criteria for execution and manner of implementation.
The radical change is also driven by the transition in the client’s expectations as per modified customer expectations. Abhishek Agarwal, Senior Vice President, Judge India explains the new hiring trends in the IT industry:
Driven to Learn and Perform
Redefined job profiles are demanding professionals with multi-disciplinary skills who believe in outcome with the scale of growth and automation in organizations. It is a golden time for leaders to push their boundaries, and for newbies to acquire more than usual responsibility. As we move forward in a culture where applications are developed for even the smallest need of tech-savvy users, the industry is open to innovators who have a keen eye for untapped delivery areas and can utilize limited resources available judiciously.
Eligibility Criteria to be Revised by HR Professionals
This shift in the outlook of industries makes the role of hiring panel more crucial as they would have to widen their horizon between traditional and newly created class of professionals. A balance has to be derived, for ensuring stability and long-term growth of the organization. The IT sector has been one of the largest employers globally and, with data becoming the new capital to invest in, Data analysts, consultants, app developers, and software managers are going to be playing an inevitable role right from the inception of any business. Owing to this emerging need in the market, IT has been one of the few sectors to bounce back with hiring activities, reaching 60 percent of its pre-COVID levels.
The influx of investments coming in for automation and the BFSI sector is bringing acceleration to IT job profiles in India. With impressive track records and large enterprise accounts, the Indian IT firms are outstanding their performance with each project they undertake from their global peers. With the upscale in the IT sector, non-IT sectors are also likely to get triggered positively once a strategic plan is into action.
The Shift of Jobs from Urban to Smaller Towns
Reshaping of industry standards is also likely to lead to the decentralization of jobs from urban clusters to smaller towns. The changes introduced by hiring professionals will not be limited to the preliminary phase but throughout the course of operations. Seminars, workshops, research, and development, would be of nature which is flexible and accessible by all with scope to accelerate diversified capabilities in all the participants.
IT Professionals could be the New Skill Developers
Apart from this, tools needed for addressing the digital gap in countries like India, it opens a segment for IT professionals who are open to the idea of training and leading by example. These unprecedented times have proven to be the right reinforcement for developing clusters of individuals, who are not just good at performing cross-industry and within their areas of expertise but can go way and beyond. The role of these multi-taskers would revolve around mentoring a circle of ambitious aspirants that are readily available as alternates and multi-level partners to alleviate the organization’s products and services further. The IT sector in these reforming times when channelized rightly can become the backbone of our developing nation. (IANS)
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study that was looking for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
"If WHO recommends this, you will see it widely taken up," said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. "We hope it will lead to a lot of lives saved."
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and "may be complementary," said Dr. Paul Sax of Brigham and Women's Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill. (VOA/RN)
Keywords: Antidepressant, Early COVID, Pandemic, Testing project
Even one of the world's most powerful tech CEOs can forget to unmute himself during a video chat. For Alphabet and Google CEO Sundar Pichai, one such embarrassing moment came as he began the chat with Kermit The Frog, a character from Muppets, on Google Meet recently. Sharing the two-minute video clip on Twitter on Wednesday, Pichai said: "Always remember to unmute thanks @KermitTheFrog for joining us on @YouTube #DearEarth and chatting about some of our shared interests."
The video was part of YouTube's "Dear Earth" series which aims to address climate challenges. "Hi there, Sundar," said Kermit, a Muppet character created in 1955, to which, Pichai replied but he was inaudible as he was on mute. "Sundar, I think you are on mute. Wow, can't believe I am talking to the CEO of Google, and he is on mute," Kermit said.
At that point, Pichai realised he was on mute. "Sorry, Kermit. I was on mute, and I've done it a few times this year like everyone else. I'm a huge fan of you and the muppets," replied the Google CEO. The video chat went smooth after the opening glitch, and Kermit The Frog and Pichai spoke about climate issues the world is grappling with. (IANS/ MBI)
Keywords: Google CEO Sundar Pichai, google meet, Kermit, dear earth, Alphabet and Google CEO.
A person's disapproval of noncommittal sex and their condemnation of recreational drug use may have a common genetic basis, suggests a study. The research, published in the journal Psychological Science, showed that moral views concerning both recreational drugs and openness to non-committed sex are approximately 50 per cent heritable, with the remaining 50 per cent explained by the unique environment.
Furthermore, approximately 75 per cent of the relationship between openness to non-committed sex and moral views concerning recreational drugs was explained by genetic effects, and the remainder was explained by the unique environment. "People adopt behaviours and attitudes, including certain moral views, that are advantageous to their own interests," said lead author Annika Karinen, a researcher at Vrije Universiteit Amsterdam in the Netherlands.
A person's disapproval of noncommittal sex and their condemnation of recreational drug use may have a common genetic basis, suggests a study. | Photo by Braňo on Unsplash
"People tend to associate recreational drug use with non-committed sex. As such, people who are heavily oriented toward high commitment in sexual relationships morally condemn recreational drugs, as they benefit from environments in which high sexual commitment is the norm," she added. The researchers also found substantial overlap in the genetic effects underlying both factors - namely, that approximately 40 per cent of the genes underlying openness to non-committed sex also underlie moral views concerning recreational drugs.
"These findings suggest that the genetic effects that influence openness to non-committed sex overlap with those that influence moral views concerning recreational drugs," said Karinen. "Important parts of hot-button culture-war issues flow from differences in lifestyle preferences between people, and those differences in lifestyle preferences appear to partly have a genetic basis."
To understand the hereditary and environmental factors, the team surveyed 8,118 Finnish fraternal and identical twins to examine how open they were to recreational drug use and to sex outside of a committed relationship. The researchers then compared fraternal and identical twin pairs to assess the extent to which condemnation of recreational drugs, openness to non-committal sex, and the relationship between the two was explained by genes; the shared environment such as growing up in the same household or community; or unique experiences and environments not shared by the twins. (IANS/ MBI)
Keywords: genes, determine, moral, values, drug, sex, genetic, environment